Kidney cancer is among the most lethal of urologic malignancies. The rising incidence of kidney cancer is attributable to greater detection of incidental small renal masses (≤4 cm) from increased use ...

Please provide your email address to receive an email when new articles are posted on . Lower rates of adverse outcomes were linked to higher technical skill Surgeons with higher scores had lower ...

FDA clears Medtronic robot for urologic surgeries, enabling use in prostatectomy, nephrectomy and cystectomy across select U.S. hospitals.

The recently developed single-port, multichannel access approach to urologic surgery may allow many common laparoscopic and robotic procedures to be performed entirely through the patient’s umbilicus, ...

Robotic surgery has become a leading option for various surgical procedures in recent years, both malignant and benign.

Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith. Robotic and minimally invasive surgery for ...

With FDA clearance, the Hugo RAS system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy — common procedures that account ...

Single‐port robotic surgery represents a significant advance in minimally invasive urology. This technique employs a dedicated robotic platform through a single incision, thereby reducing surgical ...

Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

Medtronic’s Hugo robotic-assisted surgery system receives US FDA clearance for urologic surgical procedures: Galway, Ireland ...

Medtronic has announced that the U.S. Food and Drug Administration (FDA) has cleared the Hugo robotic-assisted surgery (RAS) ...